Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
P. Rutgeerts,R. Diamond,9 Authors,S. Hanauer
2006 · DOI: 10.1016/J.GIE.2005.08.011
308 Citations
TLDR
Scheduled infliximab maintenance therapy resulted in more improvement in mucosal ulceration and in higher rates of mucosal healing, and there was a numerical trend for patients with better mucosal Healing to have a lower rate of Crohn's disease-related hospitalizations.